Walleye Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
359,100
-315,200
-47% -$8.39M 0.04% 393
2025
Q4
$16.8M Buy
674,300
+509,100
+308% +$12.8M 0.05% 372
2025
Q3
$4.21M Sell
165,200
-525,700
-76% -$13M 0.02% 1035
2025
Q2
$16.7M Buy
690,900
+133,500
+24% +$3.11M 0.07% 300
2025
Q1
$14.1M Buy
557,400
+94,500
+20% +$2.47M 0.06% 299
2024
Q4
$12.3M Sell
462,900
-112,300
-20% -$3.05M 0.03% 514
2024
Q3
$16.6M Sell
575,200
-263,700
-31% -$7.69M 0.03% 419
2024
Q2
$23.5M Buy
838,900
+44,600
+6% +$1.23M 0.04% 299
2024
Q1
$22M Sell
794,300
-235,100
-23% -$6.52M 0.04% 376
2023
Q4
$29.6M Buy
1,029,400
+276,500
+37% +$8.36M 0.06% 210
2023
Q3
$25M Buy
752,900
+365,300
+94% +$12.9M 0.06% 188
2023
Q2
$14.2M Buy
387,600
+332,400
+602% +$12.9M 0.05% 261
2023
Q1
$2.25M Buy
55,200
+17,200
+45% +$743K 0.03% 656
2022
Q4
$1.95M Buy
38,000
+14,100
+59% +$676K 0.04% 597
2022
Q3
$1.05M Buy
+23,900
New +$1.16M 0.02% 939
2019
Q4
Sell
-49,222
Closed -$1.68M 2150
2019
Q3
$1.68M Buy
49,222
+25,718
+109% +$935K 0.1% 263
2019
Q2
$966K Sell
23,504
-23,821
-50% -$946K 0.11% 282
2019
Q1
$1.91M Buy
+47,325
New +$1.9M 0.31% 46

Other funds holding PFE

Walleye Capital's PFE Position: Q1 2026 in Review

Walleye Capital increased its Pfizer (PFE) stake by 126% in Q1 2026, buying an estimated $15.9M and bringing the position to 1,070,486 shares worth $30.1M. The position accounts for 0.13% of the portfolio, ranked #95.

Walleye Capital first reported a position in PFE in Q3 2019 and has held it in 13 quarters since. The position peaked at $31.9M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Walleye Capital held 1,070,486 shares of Pfizer worth $30.1M as of Q1 2026.
  • Walleye Capital bought 596,980 Pfizer shares in Q1 2026, an estimated $15.9M.
  • Pfizer made up 0.13% of Walleye Capital's portfolio in Q1 2026, its #95 holding.
  • Walleye Capital first reported a position in Pfizer in Q3 2019 and has held it in 13 quarters since.
  • Walleye Capital's Pfizer position peaked at $31.9M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.